Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer—preliminary results of cancer and leukemia group B trial 9761
- 1 March 2002
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 123 (3) , 484-491
- https://doi.org/10.1067/mtc.2002.119883
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancerSurgery, 1999
- Expression of MUC-1 Epitopes on Normal Bone Marrow: Implications for the Detection of Micrometastatic Tumor CellsJournal of Clinical Oncology, 1999
- MUC1Expression in Hematopoietic TissuesAmerican Journal of Clinical Pathology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.Journal of Clinical Oncology, 1998
- Detection of Occult Micrometastases in Non-Small Cell Lung Carcinoma by Reverse Transcriptase-Polymerase Chain ReactionChest, 1998
- Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot-blot analysis.Journal of Clinical Oncology, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Micrometastatic tumour cells in bone marrow in colorectal cancerThe Lancet, 1993